Pfizer’s Eye-Openers: Company Licenses Insomnia, Blindness Agents
Pfizer will establish a 200-rep specialty sales force for Neurocrine Biosciences as part of a copromotion deal for Neurocrine's insomnia drug indiplon
Pfizer will establish a 200-rep specialty sales force for Neurocrine Biosciences as part of a copromotion deal for Neurocrine's insomnia drug indiplon